Related references
Note: Only part of the references are listed.Diagnosis and Management of Castleman Disease
Jeremy S. Abramson
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2019)
Clinical, laboratory and imaging findings in Castleman's disease - The subtype decides
Michael Haap et al.
BLOOD REVIEWS (2018)
Treatment of Idiopathic Castleman Disease
Frits van Rhee et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2018)
Epidemiology of Castleman Disease
David Simpson
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2018)
Treatment of Kaposi Sarcoma Herpesvirus-Associated Multicentric Castleman Disease
Kathryn Lurain et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2018)
Pathology of Castleman Disease
David Wu et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2018)
Castleman Disease Pathogenesis
David C. Fajgenbaum et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2018)
International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease
David C. Fajgenbaum et al.
BLOOD (2017)
Siltuximab: a targeted therapy for idiopathic multicentric Castleman disease
David C. Fajgenbaum et al.
IMMUNOTHERAPY (2016)
Idiopathic multicentric Castleman's disease: a systematic literature review
Amy Y. Liu et al.
LANCET HAEMATOLOGY (2016)
Siltuximab for multicentric Castleman's disease: a randomised, double-blind, placebo-controlled trial
Frits van Rhee et al.
LANCET ONCOLOGY (2014)
Polycystic ovary syndrome: etiology, pathogenesis and diagnosis
Mark O. Goodarzi et al.
NATURE REVIEWS ENDOCRINOLOGY (2011)
Iron-Deficiency Anemia in Castleman Disease: Implication of the Interleukin 6/Hepcidin Pathway
Jean-Benoit Arlet et al.
PEDIATRICS (2010)
Non-Hodgkin lymphoma in women: Reproductive factors and exogenous hormone use
Jennifer S. Lee et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)
Share Paper
